Defining the Role of SGLT2 Inhibitors in Primary Care: Time to Think Differently
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-6961
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Defining the Role of SGLT2 Inhibitors in Primary Care: Time to Think Differently ; volume:13 ; number:5 ; day:29 ; month:3 ; year:2022 ; pages:889-911 ; date:5.2022
Diabetes therapy ; 13, Heft 5 (29.3.2022), 889-911, 5.2022
- Urheber
-
Evans, Marc
Morgan, Angharad R.
Bain, Stephen C.
Davies, Sarah
Dashora, Umesh
Sinha, Smeeta
Seidu, Samuel
Patel, Dipesh C.
Beba, Hannah
Strain, W. David
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13300-022-01242-y
- URN
-
urn:nbn:de:101:1-2022071420415626084267
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Evans, Marc
- Morgan, Angharad R.
- Bain, Stephen C.
- Davies, Sarah
- Dashora, Umesh
- Sinha, Smeeta
- Seidu, Samuel
- Patel, Dipesh C.
- Beba, Hannah
- Strain, W. David
- SpringerLink (Online service)
Ähnliche Objekte (12)
Direct cardiac effects of SGLT2 inhibitors
Are we ready to think differently about setting PEEP?
Trials in rare diseases: the need to think differently
SGLT2-Inhibitoren – Effektive Blutzuckerregulation über die Niere
Comparison of incident hypertension between SGLT2 inhibitors vs. DPP4 inhibitors
Think Differently We Must! An AI Manifesto for the Future
Class effects of SGLT2 inhibitors on cardiorenal outcomes
SGLT2-inhibitors; more than just glycosuria and diuresis
The potential anti-arrhythmic effect of SGLT2 inhibitors
Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors
A Fluorescent Glucose Transport Assay for Screening SGLT2 Inhibitors in Endogenous SGLT2-Expressing HK-2 Cells
SGLT2 inhibitors and the cardiac rhythm: unraveling the connections
Direct cardiac effects of SGLT2 inhibitors
Are we ready to think differently about setting PEEP?
Trials in rare diseases: the need to think differently
SGLT2-Inhibitoren – Effektive Blutzuckerregulation über die Niere
Comparison of incident hypertension between SGLT2 inhibitors vs. DPP4 inhibitors
Think Differently We Must! An AI Manifesto for the Future
Class effects of SGLT2 inhibitors on cardiorenal outcomes
SGLT2-inhibitors; more than just glycosuria and diuresis
The potential anti-arrhythmic effect of SGLT2 inhibitors
Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors
A Fluorescent Glucose Transport Assay for Screening SGLT2 Inhibitors in Endogenous SGLT2-Expressing HK-2 Cells
SGLT2 inhibitors and the cardiac rhythm: unraveling the connections
Direct cardiac effects of SGLT2 inhibitors
Are we ready to think differently about setting PEEP?
Trials in rare diseases: the need to think differently
SGLT2-Inhibitoren – Effektive Blutzuckerregulation über die Niere
Comparison of incident hypertension between SGLT2 inhibitors vs. DPP4 inhibitors
Think Differently We Must! An AI Manifesto for the Future
Class effects of SGLT2 inhibitors on cardiorenal outcomes
SGLT2-inhibitors; more than just glycosuria and diuresis
The potential anti-arrhythmic effect of SGLT2 inhibitors
Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors
A Fluorescent Glucose Transport Assay for Screening SGLT2 Inhibitors in Endogenous SGLT2-Expressing HK-2 Cells